Ohio investor buys Trilliant majority stake

A Cleveland-based investment firm with a long history of involvement with local companies has taken a majority stake in Trilliant, the health data analytics venture that helps health systems growth their market share.

Exact terms of Primus Capital’s investment in Trilliant aren’t being disclosed. Previous investors Providence Ventures, Martin Ventures, Noro-Moseley Partners and Nashville Capital Network also took part in the recapitalization, which involved Providence Senior Partner Jeff Stolte taking a board seat.